- POSITIVE
Quarterly Revenue SBC Medical Group Holdings Jun-2026 Quarterly Revenue is $49 Million which is growth of 13.4% YoY.
- POSITIVE
Quarterly Net Profit SBC Medical Group Holdings Jun-2026 Quarterly Net Profit is $11 Million which is growth of 335.0% YoY.
5.420.08(1.50%)
156.9K
XNAS Volume
XNAS 09 Oct, 2026 5:30 PM (EDT)
SBC Medical Group Holdings quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Forecaster Analyst Estimates for SBC Medical Group Holdings share price target, revenues, EPS, net income and more
SBC Medical Group Holdings quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Rev. | 49.2 | 43.1 | 39.6 | 43.4 | 43.4 | 47.3 | 44.4 | 53.1 | 53.1 | 54.8 | 62.4 | 47.3 | ||
Cost Of Rev. | 13.2 | 12.7 | 10.6 | 12.7 | 13.4 | 9.6 | 10.6 | 9.9 | 13.7 | 15.3 | 19 | 13.8 | - | |
Gross Profit | 36 | 30.4 | 28.9 | 30.6 | 30 | 37.7 | 33.9 | 43.2 | 39.4 | 39.5 | 43.4 | 33.5 | - | |
| 17 | 12.6 | 16.1 | 14.7 | 15.5 | 13.5 | 14.1 | 29.4 | 12.1 | 15.1 | 19.4 | 13.5 | 0.5 | ||
Operating Profit | 19 | 17.7 | 12.9 | 15.9 | 14.6 | 24.2 | 19.8 | 13.8 | 27.3 | 24.5 | 24 | 20.1 | -0.5 | |
| -0.1 | 0 | -0.1 | 0.1 | -0 | 0.1 | -0 | 0 | -0 | 0 | 0.8 | ||||
Profit Before Tax | 19.6 | 18.9 | 18.6 | 18.5 | 13.5 | 31.5 | 6.1 | 13.1 | 27.1 | 27.2 | 23.6 | 21.1 | 0.4 | |
Tax | 7.8 | 7.5 | 4.3 | 5.7 | 11.1 | 10 | -0.5 | 10.3 | 8.5 | 8.5 | 9.3 | 13 | 0.2 | |
| 10.7 | 11.3 | 14.2 | 12.8 | 2.5 | 21.5 | 6.5 | 2.8 | 18.5 | 18.8 | 14.3 | 8.4 | 0.2 | ||
Diluted NI Avail to Com Stockholders Ann. | 10.7 | 11.3 | 14.2 | 12.8 | 2.5 | 21.5 | 6.5 | 2.8 | 18.5 | 18.8 | 14.3 | 8.4 | 0.2 | |
Basic EPS | 0.1 | 0.1 | 0.1 | 0.1 | 0 | 0.2 | 0.1 | 0 | 0.2 | 0.2 | 0.1 | 0.1 | 0 | |
Diluted EPS After ExtraOrdinary | 0.1 | 0.1 | 0.1 | 0.1 | 0 | 0.2 | 0.2 | 0 | 0.2 | 0.2 | 0.1 | 0.1 | 0 | |
Number Of Shares End | 102.6 | 102.6 | 102.6 | 102.6 | 103.5 | 103.3 | 102.8 | 95.1 | 100.7 | 100.7 | 100.7 | 100.7 | 9.5 | |
Net Income Continuing Discontinued Operations | 10.7 | 11.3 | 14.2 | 12.8 | 2.5 | 21.5 | 6.5 | 2.8 | 18.5 | 18.8 | 14.3 | 8.4 | 0.2 | |
Normalized Income | 10.1 | 10.8 | 12.8 | 12.8 | 2.4 | 15.5 | 18.4 | 2.8 | 18.5 | 16.1 | 14.4 | 8.4 | 0.2 | |
Interest Income | 0 | 0.1 | 0.1 | 0 | 0.1 | -0 | 0 | 0 | 0 | 0 | 0.8 | |||
Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | 0 | - | |||
Net Interest Income | -0.1 | 0 | -0.1 | 0.1 | -0 | 0.1 | -0 | 0 | -0 | 0 | 0.8 | |||
EBIT | 19.7 | 19 | 18.6 | 18.6 | 13.6 | 31.5 | 6.1 | 13.1 | 27.1 | 27.2 | 23.6 | 21.1 | -0.5 | |
EBITDA | 20.8 | 19.6 | 19.3 | 19.3 | 14.2 | 32.1 | 7 | 14.1 | 27.9 | 28.2 | 26.1 | 21.1 | -0.5 | |
Reconciled Cost Of Rev. | 12.4 | 12.4 | 10.6 | 12.7 | 13.2 | 9.4 | 10.6 | 9.9 | 13.1 | 15.2 | 19 | 13.8 | - | |
Reconciled Depr. | 1.1 | 0.7 | 0.7 | 0.8 | 0.6 | 0.6 | 0.9 | 1 | 0.8 | 1 | 2.6 | - | - | |
Profit From Continuing Operations | 11.2 | 11.3 | 14.3 | 12.8 | 2.4 | 21.5 | 6.6 | 2.8 | 18.6 | 18.8 | 14.2 | -0.1 | 0.2 | |
Normalized EBITDA | 19.8 | 18.8 | 17.4 | 19.3 | 14.1 | 23.3 | 22.1 | 14.1 | 27.9 | 24.4 | 26.2 | 21.1 | -0.5 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
SBC Medical Group Holdings competitor comparison and performance snapshot within industry
SBC Medical Group Holdings annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Annual Revenue SBC Medical Group Holdings Dec-2025 Annual Revenue is $174 Million which is growth of -15.5% YoY.
- POSITIVE
Annual Net Profit SBC Medical Group Holdings Dec-2025 Annual Net Profit is $51 Million which is growth of 9.4% YoY.
| Indicator | Graph | CAGR 3 Yrs | TTM | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|---|---|
-0.1% | 173.6 | 205.4 | 193.5 | 174.2 | |||
Cost Of Rev. Ann. | -7.9% | 49.3 | 46.3 | 49.4 | 56.2 | 59.3 | |
Gross Profit Ann. | 3.5% | 125.9 | 127.3 | 156.1 | 137.3 | 114.8 | |
Operating Exp. Ann. | -13.8% | 60.5 | 59.8 | 70.7 | 66.2 | 93.5 | |
Operating Profit Ann. | 46.7% | 65.4 | 67.5 | 85.4 | 71.1 | 21.4 | |
- | -0.1 | 0 | -0 | 0 | 0.4 | ||
Other Exp. Ann. | 96.9% | 14.5 | -11.9 | 2.5 | 1.9 | ||
PBT Ann. | 51.3% | 75.5 | 82.1 | 73.5 | 73.6 | 23.7 | |
Tax Ann. | 19.6% | 25.3 | 31 | 26.8 | 35 | 18.1 | |
100.8% | 49 | 51 | 46.6 | 39.4 | 6.3 | ||
Diluted NI Avail to Com Stockholders Ann. | 100.8% | 49 | 51 | 46.6 | 39.4 | 6.3 | |
EPS Ann. | 71% | 0.5 | 0.5 | 0.4 | 0.1 | ||
Diluted EPS Ann. | 71% | 0.5 | 0.5 | 0.4 | 0.1 | ||
Number Of Shares End | 89.4% | 102.6 | 102.8 | 100.7 | 15.1 | ||
Total Exp. Ann. | -11.4% | 106.1 | 120.1 | 122.5 | 152.8 | ||
Net Income Continuing Discontinued Operations Ann. | 100.8% | 49 | 51 | 46.6 | 39.4 | 6.3 | |
Normalized Income Ann. | 82.4% | 46.4 | 44.3 | 53.8 | 39.7 | 7.3 | |
Interest Income Ann. | -26.3% | 0.2 | 0.2 | 0 | 0.1 | 0.5 | |
Interest Ann. | - | 0.3 | 0.2 | 0 | 0.1 | 0 | |
EBITDA Ann. | 42.1% | 79.1 | 84.9 | 77.3 | 85.9 | 29.6 | |
Reconciled Cost Of Rev. Ann. | -7.9% | 48.1 | 46.3 | 49.4 | 56.2 | 59.3 | |
Reconciled Depr. Ann. | -22.9% | 3.2 | 2.7 | 3.8 | 12.3 | 5.9 | |
Profit From Continuing Operations Ann. | 109% | 49.6 | 51.1 | 46.7 | 38.6 | 5.6 | |
Normalized EBITDA Ann. | 33.9% | 75.3 | 74.2 | 88.5 | 86.3 | 30.9 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-15.5%
2Y CAGR
-5.3%
3Y CAGR
-0.1%
Net Profit Ann.
1Y CHG
9.4%
2Y CAGR
13.8%
3Y CAGR
100.8%
Operating Exp. Ann.
1Y CHG
-15.4%
2Y CAGR
-5%
3Y CAGR
-13.8%
SBC Medical Group Holdings balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund SBC Medical Group Holdings Dec-2025 Total Shareholders Fund is $248 Million which is growth of 27.3% YoY.
- POSITIVE
Total Assets SBC Medical Group Holdings Dec-2025 Total Assets is $380 Million which is growth of 43.0% YoY.
| Indicator | Graph | CAGR 3 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|---|
19.1% | 380.5 | 266.1 | 258.8 | 225.5 | ||
-0.1% | 117.1 | 71.1 | 115 | 117.6 | ||
33.1% | 248.3 | 195.1 | 142.2 | 105.3 | ||
Total Capitalization Ann. | 36.5% | 282 | 201.6 | 155.2 | 110.8 | |
Tangible Assets Ann. | 25.3% | 185.1 | 188.9 | 118.8 | 94.1 | |
Working Capital Ann. | 144.1% | 170.1 | 123.3 | 73.5 | 11.7 | |
Invested Capital Ann. | 36.1% | 291.1 | 201.7 | 158.7 | 115.5 | |
Tangible Book Value Ann. | 25.3% | 185.1 | 188.9 | 118.8 | 94.1 | |
Borrowings Ann. | 47.4% | 51.6 | 12.2 | 22.9 | 16.1 | |
Net Debt Ann. | - | - | - | 0.7 | - | |
Share Issued Ann. | 1% | 103.9 | 103 | 100.7 | 100.7 | |
Number Of Shares End | 89.4% | 102.6 | 102.8 | 100.7 | 15.1 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
43%
2Y CAGR
21.3%
3Y CAGR
19.1%
Total Current Liabilities Ann.
1Y CHG
-0.2%
2Y CAGR
-18.7%
3Y CAGR
-15.5%
Total ShareHolders Funds Ann.
1Y CHG
27.3%
2Y CAGR
32.1%
3Y CAGR
33.1%
SBC Medical Group Holdings ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share SBC Medical Group Holdings Book Value Per Share is $3 which is growth of 7.6% YoY.
- NEUTRAL
ROE SBC Medical Group Holdings ROE is 0% which is growth of 0% YoY.
| Indicator | Graph | CAGR 3 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|---|
RoA Ann. % | - | - | 17.76% | 0.48% | - | |
ROE Ann. % | - | - | 27.64% | 0.52% | - | |
ROIC % | - | - | 3 | 8.7 | -0.2 | |
OPM Ann. % | 46.9% | 38.87% | 41.56% | 36.72% | 12.26% | |
Inventory Turnover Ratio Ann. | - | - | 21.5 | - | - | |
Asset Turnover Ann. % | - | - | 0.8 | - | - | |
Working Capital Turnover Ann. | -59.4% | 1 | 1.7 | 2.6 | 14.9 | |
Quick Ratio Ann. | - | - | 2.8 | 0.1 | 0.9 | |
Current Ratio Ann. | - | - | 3 | 0.2 | 1.3 | |
Interest Coverage Ratio Ann. | - | - | 2,596.6 | - | - | |
LT Debt To Equity Ann. | - | - | 0 | - | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
SBC Medical Group Holdings cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity SBC Medical Group Holdings Dec-2025 Cash From Operating Activity is $25 Million which is growth of 19.8% YoY.
- POSITIVE
Net Cash Flow SBC Medical Group Holdings Dec-2025 Net Cash Flow is $42 Million which is growth of 25.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|---|
- | 24.7 | 20.6 | 50.6 | -0.1 | ||
- | -21 | -10.1 | 1.8 | -32.7 | ||
- | 38.3 | 23 | 6.1 | -8 | ||
Cash Plus Cash Eqv. End Of Year Ann. | 46.9% | 163.8 | 125 | 103 | 51.7 | |
Net Increase In Cash Plus Cash Eqv.s Ann. | - | 42 | 33.5 | 58.6 | -40.7 | |
Cash Plus Cash Eqv. Begin Of Year Ann. | 6.2% | 125 | 103 | 51.7 | 104.5 | |
Income Tax Paid Supplemental Data Ann. | 6.5% | 37.2 | 30.2 | 17.8 | 30.8 | |
Interest Paid Supplemental Data Ann. | - | 0.2 | 0 | 0.1 | 0 | |
Capex Ann. | - | -2.7 | -3.4 | -11.2 | -25 | |
Issuance Of Capital Stock Ann. | - | - | ||||
Issuance Of Debt Ann. | 603.4% | 34.8 | 12.1 | 12.3 | 0.1 | |
Repayment Of Debt Ann. | - | -1.7 | -0.1 | -8.7 | -5.2 | |
Repurchase Of Capital Stock Ann. | - | -5 | - | -100.1 | - | |
Free Cash Flow Ann. | - | 22 | 17.2 | 39.4 | -25 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
19.9%
2Y CAGR
-30.1%
Cash from Financing Act. Ann.
1Y CHG
66.5%
2Y CAGR
150.6%
